
Novavax, Inc. (NASDAQ:NVAX) Publishes Study for RSV-F Vaccine and Schedules Investor Meeting
Novavax, Inc. (NASDAQ:NVAX) has announced that it would be hosting its “3rd Annual Analyst and Investor conference”, on September 29, 2015 in New York. Furthermore,











